The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist

Micol Romano, Zehra Serap Arıcı, David Piskin, Sara Alehashemi, Daniel Aletaha, Karyl S. Barron, Susanne M. Benseler, Roberta Berard, Lori Broderick, Fatma Dedeoğlu, Michelle Diebold, Karen Durrant, Polly J. Ferguson, Dirk Foell, Jonathan S. Hausmann, Olcay Y Jones, Daniel L. Kastner, Helen J. Lachmann, Ronald M. Laxer, D. Doble Rivera, Nicolino Ruperto, Anna Simon, Marinka Twilt, Joost Frenkel, Hal M. Hoffman, Adriana A. de Jesus, Jasmin Kuemmerle‐Deschner, Seza Özen, Marco Gattorno, Raphaela Goldbach‐Mansky, Erkan Demirkaya